Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
50
NCT02876796
Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects
Phase: Phase 1
Role: Collaborator
Start: Aug 31, 2015
Completion: Oct 31, 2015
NCT04381182
Heart Rate Variability and Stress Management Enhancement
Phase: N/A
Start: Sep 1, 2021
Completion: Aug 20, 2022